Stand Up To Cancer, Mastercard, and the Avengers are assembling as a new team of heroes to confront another villain: cancer. A Public Service Announcement has launched featuring the Avengers: Endgame heroes and real life cancer survivors.
- This April a new team of heroes is gathering to take on one of the worst enemy of all: cancer.
- Stand Up To Cancer (SU2C), Mastercard, and Marvel’s Avengers: Endgame heroes are joining forces for a new Public Service Announcement (PSA).
- The PSA campaign features Avengers: Endgame Super Heroes alongside real-life heroes: cancer survivors.
- The two global brands are collaborating to raise awareness for SU2C to help all patients become long-term survivors.
- Aligning with the premiere of Avengers: Endgame in theaters April 26, 2019, audiences will discover the PSA across many mediums including:
- Out-of-home networks
- This PSA is the latest collaboration between SU2C and Mastercard, marking Mastercard's 10th year as a supporter of SU2C.
- This marks the second collaboration between SU2C and Marvel Studios, who collaborated with American Airlines, a longstanding donor to SU2C, on a PSA campaign tied to Avengers: Infinity War in 2018.
What they’re saying:
- Cheryl Guerin, executive vice president, North America marketing and communications, Mastercard: "It's incredible to look back at the impact our donations have had on cancer research. We are so proud of what we have been able to accomplish with the help of our cardholders over the last ten years. This new campaign gives us the extraordinary opportunity to spotlight the heroes of our community— those who have defeated cancer in their own lives. It further underscores the message that no one is alone standing up to this disease and that we are stronger when we join forces. We are so honored to collaborate with Stand Up To Cancer and Marvel Studios' Avengers: Endgame on this galvanizing PSA. Together, we want to create a future where everyone facing a cancer diagnosis becomes a long-term survivor."
- Mindy Hamilton, SVP of Marvel Partnerships: "It's a privilege to team up with Stand Up To Cancer and its long-time supporter, Mastercard, to spotlight the true heroes of our world. On behalf of the entire studio, we deeply admire the courage, strength and empowering Super Hero examples that patients and survivors continue to set. We look forward to the day when there is an end to cancer."
- Rusty Robertson, Stand Up To Cancer co-founder: "At Stand Up To Cancer, collaboration is the cornerstone of our mission. We are so grateful to Mastercard and Marvel Studios' Avengers: Endgame for standing with us, and to all the survivors who bravely share their personal journeys. This incredible collaboration illustrates how we can all be Super Heroes."
- The print PSA features Avengers: Endgame cast members:
- Brie Larson as Captain Marvel
- Chris Evans as Captain America
- Chris Hemsworth as Thor
- Survivors featured:
- Pearl, a pediatric cancer survivor
- Arnold a Myelodysplastic syndrome (MDS) survivor
- Lori, a breast cancer survivor
- Arnold and Pearl are also included in the Spanish language print PSA.
- The broadcast PSA, including TV and radio, features:
- Chris Evans
- Brie Larson
- Paul Rudd (Ant-Man)
- Karen Gillan (Nebula)
- Danai Gurira (Okoye)
- Survivors featured include:
- Dave, an esophageal cancer survivor
- Phuong, a colon cancer survivor
- Robyn, a breast cancer survivor.
About the PSA:
- Inspired by Stand Up To Cancer's UK colleagues' innovative PSA, "The Takedown," which was created and directed by Melissa Bolton-Klinger, a Stage 3 head and neck cancer survivor.
- The US adaptation and print campaign were produced by L Associates, an integrated creative agency located in Hollywood, CA that focuses on entertainment and brands.
- For more information, please visit:
- Follow @SU2C across
A positive impact:
- Mastercard launched its support for SU2C with a "Priceless" PSA which aired during the 2009 MLB World Series.
- Since then, Mastercard has continued to collaborate with SU2C, most notably on their annual dine out campaign.
- Over the last 10 years, Mastercard's donations have significantly supported SU2C's research in:
- Precision treatments
- Development of technologies such as:
- Using blood tests to identify cancers early
- Imaging cancers to understand tumor progression
- New laboratory tools to target drug discovery and precision medicine